Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair.

BACKGROUND Incidences of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, are escalating worldwide and can be considered a global public health problem. Given that the gold standard approach to IBD therapeutics focuses on reducing the severity of symptoms, there is an urgent unmet need to develop alternative therapies that halt not only inflammatory processes but also promote mucosal repair. Previous studies have identified increased stem cell factor (SCF) expression in inflamed intestinal mucosal tissues. However, the role that SCF plays in mediating intestinal inflammation and repair has not been explored. METHODS Changes in the expression of SCF were evaluated in the colonic tissue of healthy mice and during dextran sodium sulfate (DSS)-induced colitis. Furthermore, mucosal wound healing and colitis severity were analyzed in mice subjected to either mechanical biopsy or DSS treatment, respectively, following intestinal epithelial cell-specific deletion of SCF or anti-SCF antibody administration. RESULTS We report robust expression of SCF by intestinal epithelial cells during intestinal homeostasis with a switch to immune cell-produced SCF during colitis. Data from mice with intestinal epithelial cell-specific deletion of SCF highlight the importance of immune cell-produced SCF in driving the pathogenesis of colitis. Importantly, antibody-mediated neutralization of total SCF or the specific SCF248 isoform decreased immune cell infiltration and enhanced mucosal wound repair following biopsy-induced colonic injury or DSS-induced colitis. CONCLUSIONS These data demonstrate that SCF functions as a pro-inflammatory mediator in mucosal tissues and that specific neutralization of SCF248 could be a viable therapeutic option to reduce intestinal inflammation and promote mucosal wound repair in individuals with IBD.

[1]  Chenzhe Feng,et al.  Trends in Worldwide Research in Inflammatory Bowel Disease Over the Period 2012–2021: A Bibliometric Study , 2022, Frontiers in Medicine.

[2]  Fabrice Daian,et al.  The Scf/Kit pathway implements self-organized epithelial patterning. , 2021, Developmental cell.

[3]  N. Lukacs,et al.  Stem Cell Factor Neutralization Protects From Severe Anaphylaxis in a Murine Model of Food Allergy , 2021, Frontiers in Immunology.

[4]  S. Koch,et al.  Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model. , 2021, Journal of visualized experiments : JoVE.

[5]  Andrés J. García,et al.  Desmocollin-2 promotes intestinal mucosal repair by controlling integrin-dependent cell adhesion and migration , 2020, Molecular biology of the cell.

[6]  J. Gisbert,et al.  Predictors of primary response to biologic treatment (anti-TNF, vedolizumab and ustekinumab) in patients with inflammatory bowel disease: from basic science to clinical practice. , 2019, Journal of Crohn's & colitis.

[7]  S. Kunkel,et al.  Inhibition of the Stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease. , 2019, American journal of physiology. Lung cellular and molecular physiology.

[8]  A. Nusrat,et al.  Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo , 2019, Nature Communications.

[9]  T. H. Nguyen,et al.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[10]  N. Lukacs,et al.  Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease , 2018, Mucosal Immunology.

[11]  H. Clevers,et al.  Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling. , 2018, Cell reports.

[12]  Guilan Li,et al.  SCF/c-KIT signaling promotes mucus secretion of colonic goblet cells and development of mucinous colorectal adenocarcinoma. , 2018, American journal of cancer research.

[13]  Guilan Li,et al.  SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma , 2018, International journal of molecular sciences.

[14]  D. Repsilber,et al.  Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles , 2017, PloS one.

[15]  T. Denning,et al.  Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling. , 2017, The Journal of clinical investigation.

[16]  L. Peyrin-Biroulet,et al.  Ulcerative colitis , 2017, The Lancet.

[17]  James M. Dahlhamer,et al.  Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. , 2016, MMWR. Morbidity and mortality weekly report.

[18]  C. Fiocchi,et al.  Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.

[19]  O. Farokhzad,et al.  Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. , 2015, The Journal of clinical investigation.

[20]  F. Cominelli,et al.  Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease , 2015, Clinical pharmacology and therapeutics.

[21]  J. Huizinga,et al.  Interstitial Cells of Cajal: Pathology, injury and repair. , 2012, Sultan Qaboos University medical journal.

[22]  Johan Lennartsson,et al.  Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.

[23]  P. Secchiero,et al.  JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. , 2012, Inflammatory bowel diseases.

[24]  S. Quake,et al.  Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. , 2012, Gastroenterology.

[25]  J. Flanagan,et al.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.

[26]  D. C. Cara,et al.  Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF): a chemoattractive agent for murine leukocytes in vivo , 2011, Journal of leukocyte biology.

[27]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[28]  D. Margulies,et al.  Surface Binding Inhibitors of the SCF–KIT Protein–Protein Interaction , 2009, Chembiochem : a European journal of chemical biology.

[29]  E. Carter,et al.  Epidermal stem cell factor augments the inflammatory response in irritant and allergic contact dermatitis. , 2008, The Journal of investigative dermatology.

[30]  L. Reber,et al.  Stem cell factor expression, mast cells and inflammation in asthma , 2006, Fundamental & clinical pharmacology.

[31]  Daniel Metzger,et al.  Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.

[32]  R. Olivenstein,et al.  The expression of stem cell factor and c‐kit receptor in human asthmatic airways , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  P. Lincoln,et al.  Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses , 2004, Clinical and experimental immunology.

[34]  F. Cavalli,et al.  A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. , 2003, Blood.

[35]  A. Ullrich,et al.  Beyond Herceptin and Gleevec. , 2003, Current opinion in chemical biology.

[36]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[37]  J. Malm,et al.  Expression of the neutrophil‐activating CXC chemokine ENA‐78/CXCL5 by human eosinophils , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[38]  J. Soboloff,et al.  Mast cells stimulated by membrane-bound, but not soluble, steel factor are dependent on phospholipase C activation , 2003, Cellular and Molecular Life Sciences CMLS.

[39]  F. Levi-Schaffer,et al.  Human peripheral blood eosinophils express stem cell factor. , 2001, Blood.

[40]  M. Neurath,et al.  Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. , 2001, The Journal of allergy and clinical immunology.

[41]  K. Zsebo,et al.  Measurement of Human and Murine Stem Cell Factor (c‐kit Ligand) , 1992, Current protocols in immunology.

[42]  Yaping Chen,et al.  Insights from mouse models of colitis , 2000, Journal of leukocyte biology.

[43]  Grabbe,et al.  Human Mast Cells Produce and Differentially Express Both Soluble and Membrane‐Bound Stem Cell Factor , 1999, Scandinavian journal of immunology.

[44]  A. Imaoka,et al.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain , 1998, Gut.

[45]  D. Metcalfe,et al.  Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. , 1997, The Journal of clinical investigation.

[46]  J. Abrams,et al.  A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection , 1996, The Journal of experimental medicine.

[47]  D. Taub,et al.  Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. , 1996, Journal of immunology.

[48]  D. Taub,et al.  The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. , 1996, Blood.

[49]  J. Peterson,et al.  A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin , 1995, The Journal of experimental medicine.

[50]  M. Neurath,et al.  Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.

[51]  J. Abkowitz,et al.  Stem cell factor production by human marrow stromal fibroblasts. , 1995, Experimental hematology.

[52]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[53]  D. Williams,et al.  Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. , 1993, The New England journal of medicine.

[54]  R. Braun,et al.  Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophore , 1993, European journal of immunology.

[55]  M. Heinrich,et al.  Constitutive expression of steel factor gene by human stromal cells. , 1993, Blood.

[56]  S. Nishikawa,et al.  Requirement of c-kit for development of intestinal pacemaker system. , 1992, Development.

[57]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[58]  P. Leder,et al.  The kit ligand: A cell surface molecule altered in steel mutant fibroblasts , 1990, Cell.

[59]  C. March,et al.  Identification of a ligand for the c-kit proto-oncogene , 1990, Cell.

[60]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[61]  A. Bernstein,et al.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.

[62]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.